Fukamizu, A
Lisco and colleagues published a review of the risks of GLP-1s and thyroid cancer in the journal Endocrine Connections in 2023, and although they describe evidence for a risk of thyroid cancer, they conclude: It is reasonable to continue prescribing GLP-1RAs due to the evidence of more relevant and well-recognized antihyperglycemic, cardiovascular, and renal benefits, with the management staying within current recommendations. If you are considering taking a GLP-1 but are concerned about the risk of thyroid cancer, you should discuss it with your doctor
Wang XQ, Xu SW, Wang W, Piao SZ, Mao XL, Zhou XB, et al
Care Res
She is dual board-certified in Internal Medicine and Obesity Medicine
By inference from related viruses, RNA synthesis is likely to be semiconservative and asymmetric: the positive-strand genome serves as a template to make a negative-strand intermediate